FDA Regulation and the Dynamic Nature of AI

• by kffconnorg

• September 15, 2026

Photodynamic therapy gains FDA approval for superficial BCC

Phase 3 trial data showed greater clinical and histological clearance than with placebo photodynamic therapy.

• by Kathryn Wighton

• September 15, 2026

• 2 min

Europe’s Cataract Benchmark

EUREQUO data from more than 363,000 procedures show improving visual outcomes and low complication rates across Europe

• September 15, 2026

• 2 min

Correction: Electroencephalographic power spectrum changes in cerebral small vessel disease combined with cognitive dysfunction and its relationship with neutrophil/lymphocyte ratio and its clinical value—A pilot study

• by Xiaomin Guo, Zongwei Liu, Weishuai Yuan, Aiqin Wei, Guogang Luo

• September 15, 2026